On May 16, 2022, it was announced that Natalie Cummins, Senior Vice President and Chief Commercial Officer for BioReference, was one of 45 honorees named Crain’s New York Business Notable Leaders in Advertising, Marketing and Public Relations in 2022. As Crain’s writes: “In selecting the 45 individuals for this 2022 list of Notable Leaders in […]
Author Archives: Erika Erdmann
Every 40 seconds, someone in the United States has a stroke, according to the Centers for Disease Control and Prevention (CDC).1 Stroke is a leading cause of death and long-term disability in the U.S., but did you know – about 80% of strokes are preventable?2 For National Stroke Awareness Month, we’re sharing information about how […]
Cancer affects one in three Americans with rippling impacts effecting families and communities. This sobering statistic is the focus of specialized researchers across the country, fighting to make discoveries that can improve and save lives. Which is why funding for just one project or study is so vital when it comes to cancer research – […]
Mother’s Day kicks off a special health observance each year – National Women’s Health Week. Driven by the U.S. Department of Health and Human Services’ Office on Women’s Health, this annual initiative encourages women of all ages to check in on their individual health needs. Here, we’re breaking down information about some common health concerns […]
Along with warmer weather and blooming flowers, the month of May brings Asthma and Allergy Awareness Month – a time to draw attention to these conditions and how they can intersect. More than 25 million people in the United States have asthma, according to the Asthma and Allergy Foundation of America (AAFA), and allergic asthma […]
Effective May 2nd, GeneDx, formerly a subsidiary of BioReference, has been acquired by Sema4. We’d like to take a moment to reflect on the work that BioReference and GeneDx have accomplished together – helping hundreds of thousands of patients benefit from genomic information to make important health decisions. At BioReference | GenPath, we remain committed to […]
Each year, the last week of April brings a special time to recognize the dedicated individuals at the core of BioReference – Laboratory Professionals. Since 1975, the American Society of Laboratory Science (ASCLS), with the support of 17 national organizations, has taken this time to observe the contributions of laboratory professionals to the field of […]
In 2022, it’s estimated that 9,910 new cases of testicular cancer will be diagnosed in the United States, according to the American Cancer Society.1 This April, for Testicular Cancer Awareness Month, we’re highlighting some key information to help raise awareness and encourage education – read on for five important things to know about testicular cancer. […]
The birds and the bees are buzzing in April with the arrival of spring – what better time to bring sexual health into the conversation for STI Awareness Month. Whether you call them sexually transmitted infections (STI) or sexually transmitted diseases (STD) – it’s important to talk about this crucial component of sexual and overall […]
LabPulse.com Healthcare technology company Cue Health and BioReference Laboratories have announced that the Cue Clinic dashboard point-of-care solution will be made available to BioReference’s clinical customers, including healthcare providers and point-of-care clinics in the U.S., as part of BioReference’s product lineup. The Cue Clinic dashboard offers analytics, reporting solutions, and application programming interface (API) integrations […]